|
Market Cap (24-Jun) $229,103,600 (1,730th) |
Close (30-Jun) $0.020 |
Volume (30-Jun) 31,196 |
Shortsold (26-May) 1,000,000 (0.04%) (508th) |
|
52w High $0.110 |
52w Low $0.030 |
P/E 19.69 |
EPS 0 |
BXN released this announcement to the ASX on 28 April 2022, 8:19. The announcement is marked as price sensitive, and is 8 page(s) in length and 246.97kb in size.
You can view all announcements from BXN and see how they appear on a price chart on the announcements page.
At the date of this announcement, BXN was 0.000% short sold according to ASIC data. It was ranked the 595th most shorted stock on the ASX. It is now ranked as the 508th most shorted stock on the ASX with 0.044% of total shares short sold as of the latest reported data (26 May 2026).
| Other Recent Announcements from BXN | |
|---|---|
| Bioxyne Launches BLS Clinics - Online Healthcare | 13 June 2023, 9:05 |
| Becoming a substantial holder | 8 June 2023, 16:36 |
| Becoming a substantial holder | 31 May 2023, 17:30 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 April 2022, 8:19 |
| Change of Director's Interest Notice | 22 March 2022, 19:07 |
| Appendix 4D and Interim Report | 22 February 2022, 11:42 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 31 January 2022, 8:52 |
You must be logged in to post a reply.
Bioxyne 